Search Browse Earnings

Vivos Therapeutics, Inc.

Nasdaq:VVOS

Surgical & Medical Instruments & Apparatus·LITTLETON, CO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Vivos Therapeutics, Inc. — SlamSEC

Revenue

$13.8M

-13.9% YoY

FY 2024

Adj. EBITDA

-$16.7M

-120.8% margin

FY 2024

Net Income

-$13.6M

-98.4% margin

FY 2024

EPS (Diluted)

-$11.14

FY 2024

Stock Price

$1.33

-2.9%

2026-03-06

52W Range

$1.29 – $7.95

P/E Ratio

-0.1x

Market Cap

$12.0M

Cash

$1.6M

FY 2024

Total Debt

$423,000

FY 2021

Net Cash

$1.2M

FY 2021

Enterprise Value

$10.7M

Debt / EBITDA

0.1x

FY 2024

EV / EBITDA

-0.6x

Employees

—

CEO

Huntsman Ronald Kirk

CFO

Amman Bradford K.